Production (Stage)
Maze Therapeutics, Inc.
MAZE
$12.93
-$0.41-3.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 294.37M | 196.81M | 149.61M | 29.16M | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 5.33M | 4.86M | 4.25M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 100.00K | -- | |
| Total Current Assets | 299.71M | 201.67M | 153.96M | -- | |
|
|
|||||
| Total Current Assets | 299.71M | 201.67M | 153.96M | -- | |
| Net Property, Plant & Equipment | 28.80M | 29.92M | 30.93M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 4.34M | 8.95M | 7.59M | -- | |
| Total Assets | 332.84M | 240.54M | 192.48M | -- | |
|
|
|||||
| Total Accounts Payable | 2.40M | 1.94M | 1.02M | -- | |
| Total Accrued Expenses | 11.54M | 14.10M | 11.70M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 4.67M | 4.63M | 4.62M | -- | |
| Total Finance Division Other Current Liabilities | -- | -- | 217.00K | -- | |
| Total Other Current Liabilities | -- | -- | 217.00K | -- | |
| Total Current Liabilities | 18.62M | 20.67M | 17.56M | -- | |
|
|
|||||
| Total Current Liabilities | 18.62M | 20.67M | 17.56M | -- | |
| Long-Term Debt | -- | -- | 51.75M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 21.15M | 22.00M | 22.80M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 1.01M | 969.00K | 1.01M | -- | |
| Total Liabilities | 40.77M | 43.64M | 93.11M | -- | |
|
|
|||||
| Common Stock & APIC | 683.28M | 47.24M | 29.34M | -- | |
| Retained Earnings | -391.21M | -358.43M | -313.88M | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 292.07M | -311.18M | -284.53M | -373.85M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | 508.09M | 383.90M | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | 508.09M | 383.90M | 383.90M | |
|
|
|||||
| Total Common Equity | 292.07M | -311.18M | -284.53M | -373.85M | |
| Total Preferred Equity | -- | 508.09M | 383.90M | 383.90M | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 292.07M | 196.90M | 99.37M | 10.05M | |
|
|
|||||